Loma Linda's First HAI Pump Patient Got Another Path After Stage 4 Colorectal Cancer
David Gutierrez became Loma Linda's first hepatic artery infusion pump patient after colorectal cancer spread to his liver, giving a local access angle to a specialized treatment path.
- Published
- Jun 27, 2026
- Last updated
- Jun 27, 2026
- Last reviewed
- Jun 27, 2026
- Status
- Confirmed
- Primary source
- Loma Linda University Health
- Verification
- Source + regulatory context
- Confidence
- very high
- Urgency
- high
Rapid orientation
The 5-second read
- What happened
- This is an advanced-cancer access and treatment-path milestone. It is not a cure claim.
- Why it matters
- Colorectal cancer that spreads to the liver can become a life-limiting problem where local liver control matters.
- Status
- Confirmed
- Overclaim risk
- High
- Primary source
- Loma Linda University Health (Official)
- Next thing to watch
- Tumor response, whether liver metastases become operable, treatment toxicity, and whether Loma Linda expands HAI access to more patients.
Signal context
Known so far
- Patient
- David Gutierrez
- Cancer
- Stage 4 colorectal cancer with liver metastases
- Treatment route
- Hepatic artery infusion pump plus systemic therapy
- Goal
- Shrink liver metastases and potentially open a future surgery path
Claim Check
ConfirmedDavid Gutierrez became Loma Linda's first hepatic artery infusion pump patient after stage 4 colorectal cancer with liver metastases.
Safe framing
This is an advanced-cancer access and treatment-path milestone. It is not a cure claim.
What happened
Loma Linda University Health reported that David Gutierrez became its first patient to receive a hepatic artery infusion pump after stage 4 colorectal cancer spread to his liver.
The pump delivers chemotherapy through the liver's blood supply, creating a more targeted route for liver metastases while the patient continues systemic treatment and monitoring.
The human angle is not a miracle cure. It is the possibility of converting an inoperable liver-metastasis situation into a future surgical path, closer to home.
Vital Signals
Get the weekly health signal without the wellness fog.
A clean weekly brief covering longevity science, fitness, nutrition, medicine, health culture, and the claims worth questioning.
No spam. No miracle claims. Just better health signal.
By subscribing, you agree to receive email from Viral Vitalism. Unsubscribe anytime. See our Privacy Policy.
Why it matters
- Colorectal cancer that spreads to the liver can become a life-limiting problem where local liver control matters.
- Specialized programs often exist far from patients, making local access a real patient benefit.
- This story has a concrete next milestone: response and possible surgery, not vague hope.
What not to overclaim
- Do not call HAI pump therapy curative for this patient.
- Do not imply all stage 4 colorectal cancer patients are candidates.
- Do not omit that he is still being monitored and treated.
Signal context
Context
- Primary topic
- Cancer Therapy
- Source date
- Jun 19, 2026
- Source stack
- 2 sources
- Current status
- Confirmed
Evidence trail
Source stack
- PrimaryOfficialJun 19, 2026Loma Linda University Health: first HAI pump patient
- Additional contextOfficialNational Cancer Institute: hepatic arterial infusion definition
Keep following the signal
Related signal trail
Human Breakthrough Desk
Help us find and amplify more stories like this.
Some health stories should not vanish after one news cycle. Support the independent desk finding patient wins, medical breakthroughs, and human stories worth moving.
Support the Human Breakthrough Desk